TNF and triple-A syndrome: In clinical and experimental AAA, a number of pro-inflammatory cytokines are increased, such as monocyte chemoattractant protein 1 (MCP-1), interleukin-1β (IL-1β), IL-6, and tumor necrosis factor-α (TNF-α).